Avenue therapeutics inc.

Major-Pharmaceuticals

ATXI


2 Gansevoort Street
New York , NY 10014

Executive/
Director

Price

  • Last Close
  • $ 0.13
    $ +0 1.53 %
    Apr 19, 2024
  • 52-Week High/Low
  • $0.83 - $0.12
  • YTD
  • 0%

  • Trading Volume
  • 14,902
  • Market Cap Full
  • $ 1.7M
  • Shares Outstanding
  • 13.2M
    Nov 8, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 - 24.6% -12% -5% 8.2% -47% 0.9% -9.2% - -
Q2 -3.6% -25.4% 22.6% 4% -58.7% -44.1% -1.7% - - -
Q3 -30.4% -24% -2.5% 8% -40.6% 3647.2% -38.8% - - -
Q4 -34.5% 95.7% 63.3% -48.3% -39.1% -88.5% -76.4% - - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 - - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    0%0%49%77%-41%-84%28%-86%-18%0%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 - -1.03 -0.82 -0.08 -0.06 -2.1 -1.35
Q2 0.54 -0.45 -0.43 -0.11 -0.06 -0.45 -0.52
Q3 0.30 -0.25 -0.14 -0.06 -0.05 -0.45 0.06
Q4 0.63 -0.37 -0.26 -0.06 -0.7 1.37 -
A 1.5 -2.1 -1.7 -0.3 -0.2 -1.6 -1.81

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 16.5 16.7 16.7 21.7 5.9
Jun 10.6 16.6 16.7 16.7 22.1 7.9
Sep 10.6 16.6 16.7 16.7 22.1 8.2
Dec 10.7 16.7 16.7 18.7 4.8 13.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 2 - - - -
Equity multiplier - - - - -